| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.2 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |